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Aims We thought to evaluate feasibility of continuous non-invasive blood pressure monitoring during procedures of inter-
ventional electrophysiology.
Methods and
results
We evaluated continuous non-invasive ﬁnger blood pressure (BP) monitoring by means of the Nexﬁn device in 22
patients (mean age 70+24 years), undergoing procedures of interventional electrophysiology, in critical situations of
hypotension caused by tachyarrhythmias or by intermittent incremental ventricular temporary pacing till to the
maximum tolerated systolic BP fall (mean 61+14 mmHg per patient at a rate of 195+37 bpm). In all patients,
Nexﬁn was able to detect immediately, at the onset of tachyarrythmia, the changes in BP and recorded reliable wave-
forms. The quality of the signal was arbitrarily classiﬁed as excellent in 11 cases, good in 10 cases, and sufﬁcient in 1
case. In basal conditions, calibrations of the signal occurred every 49.2+24.3 s and accounted for 4% of total moni-
toring time; during tachyarrhythmias their frequency increased to one every 12.7 s and accounted for 19% of total
recording duration. A linear correlation for a range of BP values from 41 to 190 mmHg was found between non-inva-
sive and intra-arterial BP among a total of 1055 beats from three patients who underwent simultaneous recordings
with both methods (coefﬁcient of correlation of 0.81, P , 0.0001).
Conclusion In conclusion, continuous non-invasive BP monitoring is feasible in the clinical practise of an interventional electro-
physiology laboratory without the need of utilization of an intra-arterial BP line.
-----------------------------------------------------------------------------------------------------------------------------------------------------------
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Introduction
It is common practise, during some invasive electrophysiology pro-
cedures, to continuously monitor arterial blood pressure (BP) by
means of an intra-arterial line. This procedure implies the risk of
complications due to the vascular access, an increase of the pro-
cedural time, and causes some discomfort to the patient.
Continuous (beat-to-beat) non-invasive BP measurement is
widely used in research, anaesthesiology, and tilt laboratories. The
most used devices are those which use the method of Penaz to
record the arterial waveform indirectly from a ﬁnger. Studies on
its accuracy have suggested little systematic bias vs. intra-arterial
pressure or non-invasive intermittent BP measurements.
1,2
We thought to evaluate feasibility continuous non-invasive BP
monitoring during procedures of interventional electrophysiology.
Method
Continuous (beat-to-beat) non-invasive BP was measured with the
Nexﬁn monitor (BMEYE B.V, Amsterdam, The Netherlands) which
uses the latest implementation of the Finapres method.
3–6 The
Finapres method is based on the volume-clamp methodology of
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7 and the Physiocal criteria.
8 Arterial blood volume in the
ﬁnger is determined with by an optical plethysmograph mounted
in an inﬂatable cuff system. A controlled pneumatic cuff system
around the ﬁnger clamps the artery at its ‘unloaded’ volume, so
that transmural pressure is zero throughout the cardiac cycle.
The unloaded volume is detected by periodical calibration called
‘Physiocal’ (Physiological Calibration). During a Physiocal, cuff air
pressure is held at varying steady levels and the plethysmogram
is observed by the pulsating intra-arterial pressure. The amplitude
and shape of plethysmogram determine the volume-clamp level
and servo system loop gain automatically. This is regularly repeated
during the measurement as the unloaded volume may change with
different physiological states of the vasculature. The duration of a
standard Physiocal is one or two beats, but can be prolonged in
case of low signal/low perfusion. The ﬁnger cuff pressure waveform
equals ﬁnger arterial pressure and can be measured for several
hours.
9 The Nexﬁn, using the same basic principles, has been rede-
signed to allow the use of present-day hardware, software, and
physiological models. The ﬁnger cuffs have been redesigned with
modern optical components for better signal to noise ratio.
Nexﬁn provides reconstructed brachial arterial BP while Finapres
gave raw ﬁnger arterial BP values.
3–6 The arterial BP wave
changes shape as it travels along the arteries, with systolic pressure
increasing while diastolic and mean pressure decrease. These
effects are compensated by applying a physiological model, yielding
brachial BP ﬁnger arterial BP.
We evaluated a non-invasive continuous BP monitoring system
in 22 patients undergoing procedures of interventional electro-
physiology in critical situations of hypotension caused by tachyar-
rhythmias or by temporary ventricular pacing at rates ranging
between 100 and 280 bpm. An appropriate-sized ﬁnger cuff was
applied to the midphalanx of the left middle ﬁnger. The cuffed
ﬁnger was positioned at the midthoracic level to avoid hydrostatic
pressure differences. Attention was paid to avoid cold ﬁngers
during initiation of the measurement that are usually associated
with reﬂex arteriolar vasoconstriction and can interfere with
proper measurement of the plethysmogram.
2 Artiﬁcial pacing
was performed, by repeated intermittent sequences of pacing for
30 s, at increasing steps of 20 bpm, till the maximum tolerated
BP fall, or the loss of 1:1 ventricular capture.
The following outcomes were measured: (i) quality of the
pulse waveforms (at rest and during high rates), evaluated by
an independent observer who was asked to classify it arbitrarily
as excellent (waveforms of good shape, amplitude, velocity and
area, dicrotic notch visible, very similar to intra-arterial signal),
good (as the previous but sometimes with non-physiological
abrupt rising pressure waves and artefacts), sufﬁcient (waveforms
of different shape, amplitude, velocity and area, frequent non-
physiological abrupt rising pressure waves but still adequate to
trust, dicrotic notch not visible and frequent calibrations), and
insufﬁcient (impossibility of recording adequate waveforms;
Figures 1 and 2); (ii) frequency of calibrations (and their percen-
tage on total monitoring time), at baseline and during incremental
rates; (iii) time delay between onset of tachyarrhythmia and BP
wave detection. In addition, in three patients, the intra-patient
linear correlation between non-invasive and invasive BP value
changes during incremental high rates were evaluated by means
of simultaneous measurements of non-invasive and intra-arterial
BP (femoral in two and radial in one) during the supine baseline
state and during ventricular temporary pacing. Intra-arterial
femoral BP was measured by means of the EMS device
(Mennen Medical, Israel). The BP values for each individual beat
were manually analysed. The resulting linear regression equation
was calculated and the comparison between the two methods
was made by means of the Pearson coefﬁcient of correlation.
Finally, the feasibility of non-invasive continuous monitoring was
evaluated in 100 consecutive patients undergoing interventional
electrophysiology.
Results
The characteristics for the 22 patients (18 males) are shown in the
Table 1. Structural heart disease was present in 11 of them (ischae-
mic in 5, valvular in 4, dilated in 2); the others had primary
arrhythmias.
During baseline recordings, the quality of the signal was arbitra-
rily classiﬁed as excellent in 14 cases (Figures 1 and 2A), good in 7
cases (Figure 2B), and sufﬁcient in 1 case (Figure 2C). The coefﬁcient
of correlation between Nexﬁn BP and automatic intermittent bra-
chial cuff BP was 0.85 (regression equation: y ¼ 0.86 × 21.9 (P ¼
0.0001).
In total, 102 episodes of tachyarrhythmia were recorded in 22
patients (incremental ventricular pacing in 100 cases and induced
ventricular tachycardia in 2 cases): of these, 79 episodes caused a
fall in systolic BP to an absolute value ,100 mmHg with a mean
fall of 64.9+22.3 mmHg. At the onset of tachyarrythmia, Nexﬁn
was able to immediately detect the changes in BP in all patients
Figure 1 Simultaneous beat-to-beat comparison between inva-
sive and Nexﬁn blood pressure waves in a patient in whom it was
classiﬁed as excellent (waveform identical to invasive signal).
Non-invasive continuous blood pressure monitoring 1617Figure 2 (A) Baseline Nexﬁn blood pressure waves in a patient in whom it was classiﬁed as excellent (waveform of good shape, amplitude,
velocity and area, dicrotic notch visible, very similar to invasive signal). (B) Baseline Nexﬁn blood pressure waves in a patient in whom it was
classiﬁed as good (waveforms as the previous but sometimes non-physiological abrupt rising pressure and artefacts). (C) Baseline Nexﬁn blood
pressure waves in a patient in whom it was classiﬁed as sufﬁcient (waveforms of different shape, amplitude, velocity and area, non-physiological
abrupt rising pressure waves, but still adequate to trust, dicrotic notch not visible and frequent calibrations); the different systolic blood pressure
peaks are consistent with different blood pressure values due to rhythm irregularity so that waveforms seem still adequate to trust.
M. Roberto et al. 1618and recorded reliable waveforms for the whole duration of the
tachyarrhythmia. Speciﬁcally, Nexﬁn was able to detect BP wave-
forms even in the recordings in which BP suddenly dropped to
,100 mmHg (Figures 3–5). Whereas in basal conditions the
system performed calibration of the signal every 49.2+24.3 s
(or 52.8+20.4 beats) for 2.5 s each corresponding to 4% of
total monitoring time, during tachyarrhythmias the frequency of
calibrations increased to one every 12.7 s (40.1+23.7 beats)
on average: in total there were 260 calibrations during 3.323 s
of recording, corresponding to 19% of total recording duration.
In particular, there were 23 episodes of ventricular tachyarrhyth-
mia at a heart rate ≥200 bpm (mean heart rate 221+24 bpm).
During these episodes the mean BP measured with Nexﬁn was
101.3+23.7 mmHg; calibrations occurred every 12.5 s (41.3+
20.6 beats) corresponding to 21.4% of total recording time. The
quality of the signal was arbitrarily classiﬁed as excellent in 11
cases, good in 10 cases, and sufﬁcient in 1 case.
...............................................................................................................................................................................
Table 1 Characteristics for the 22 study patients
Range Median (P25; P75) Mean+ + + + +SD
Age, years 20–98 77 (62; 82) 70+24
Height, cm 152–180 173 (169; 178) 172+7
Weight, Kg 50–85 73 (65; 79) 72+9
Baseline intermittent systolic BP by automatic brachial cuff device
a, mmHg 80–180 146 (121; 154) 140+26
Baseline continuous systolic BP by ﬁnger Nexﬁn
b, mmHg 88–184 143 (120; 157) 138+26
Tachycardia sequences, bpm 100–280 160 (120; 180) 159+42
Maximum heart rate per patient 140–280 180 (160; 220) 195+37
Minimum measured BP per patient 41–87 60 (49; 73) 61+14
P25 and P75 give the 25th and 75th percentiles.
BP, blood pressure.
aValue determined by average of three measurements per patient.
bValue determined by average of measurements performed during 30 s per patient.
Figure 3 Simultaneous beat-to-beat comparison between invasive and Nexﬁn blood pressure waves during a period of 30 s of ventricular
pacing at 140 bpm.
Non-invasive continuous blood pressure monitoring 1619Figure 4 Patient’s case. Blood pressure curve during ventricular pacing at 240 bpm for 30 s. Automatic calibration of the system for a period
of 2.5 s toward the end of the pacing period.
Figure 5 Ventricular pacing at increasing rate from 100 to 220 bpm in a 81-year-old-patient. Blood pressure curves are sometimes inter-
rupted by periods of 2.5 s of automatic calibration of the system. Pacing at 220 bpm was prematurely interrupted because the patient had
impending syncope. At heart rates of 180 and 200 bpm there are two classical examples of artefacts.
M. Roberto et al. 1620A total of 1055 beats (from 16 sequences of pacing at rate
ranging 100–240 bpm) was manually analysed in the three patients
who underwent simultaneous recording of Nexﬁn and
intra-arterial BP. A linear correlation was found between the
two methods for a range of BP values from 41 to 190 mmHg (coef-
ﬁcient of correlation of 0.81, P , 0.0001; Figure 6). The average
precision was 16.9+10.5 mmHg.
Finally, we have successfully replaced intra-arterial BP monitor-
ing with Nexﬁn BP monitoring during 100 standard procedures
of invasive electrophysiology. We were able to obtain reliable BP
monitoring in all except two patients who had insufﬁcient quality
of the signal due to severe impairment of ﬁnger arterial vasculari-
zation as a consequence of systemic atherosclerosis.
Discussion
We showed that continuous non-invasive ﬁnger BP monitoring
provides reliable arterial waveforms even in critical situations of
sudden onset of high and very high ventricular rate and of
severe hypotension such as those observed in a laboratory of elec-
trophysiology. The beat-to-beat waves are immediately detected at
the onset of tachyarrhythmia (thus providing an immediate param-
eter of the haemodynamic status of the patient even before the
onset of hypotensive symptoms) and, even if detection is inter-
rupted by frequent episodes of calibration, the percentage of
measured beats is largely sufﬁcient for a continuous monitoring
of the haemodynamic status of the patient. Therefore, non-invasive
ﬁnger BP monitoring can safely replace the intra-arterial monitor-
ing during interventional electrophysiology procedures.
The Finapres method, of which Nexﬁn is an evolution, has been
utilized in a variety of settings, such as drug-induced hypotension
during hypotensive anaesthetic techniques,
10–12 tilt testing,
13–16
Valsalva manoeuvre,
17,18 and exercise stress tests.
19,20 However,
it has not yet been used during interventional electrophysiology.
The validation of non-invasive continuous BP monitoring
systems is outside the scope of this study. However, studies on
the accuracy of Finapres have suggested little systematic bias vs.
intra-arterial pressure but substantial variability. In combined data
from 20 published studies for a total of 449 patients,
1 the
average systolic bias was 2.2+12.4 mmHg. The average precision
was 12.1+8.4 mmHg. The calculated percentage of Finapres sys-
tolic values expected to fall within +10 mmHg of the direct
intra-arterial pressure was 73.1%. Although the observed variability
creates some concern in research trials, there is general agreement
that Finapres accuracy and precision usually sufﬁce for reliable
tracking in the clinical practise.
1,2 Using the Nexﬁn on the same
basic principles of Finapres, we assumed that its accuracy is the
same as that of Finapres. In addition, in a recent study performed
in 104 subjects (aged 18–95 years),
3 Nexﬁn provided accurate
measurement of BP with good within-subject precision when com-
pared with brachial auscultatory BP measurements (Riva-Rocci/
Korotkoff). Brachial systolic BP was 129 (interquartile range 115,
150). Nexﬁn difference was 5.4 (21.7, 11.0) mmHg; within-subject
precisions was 22.2 to 2.3. These results are fairly consistent with
the correlation observed in this study between Nexﬁn and inter-
mittent non-invasive BP baseline measures.
The impossibility of measuring the plethysmogram in the ﬁnger
due to the combination of vascular disease, ambient cold tempera-
ture and other reasons is reported to occur in the literature in
 1% of patients.
2,21 We observed a similar 2% failure rate in
our patients.
Limitations
The study population was small and polymorphic. The potential
difference between Nexﬁn and Finapres or similar devices is that
Nexﬁn’s ﬁnger cuffs have been redesigned with modern optical
components for better signal to noise ratio and that Nexﬁn pro-
vides reconstructed brachial arterial BP while Finapres gave raw
ﬁnger arterial BP values. In this study, Nexﬁn was not compared
with other available devices; thus, the results of this study apply
to the Nexﬁn device and may not necessarily be reproduced
with other devices measuring continuous non-invasive BP.
Although the correlation with invasive BP was sufﬁciently validated
with Finapress,
1,2 this correlation in critical situations of hypoten-
sion caused by tachyarrhythmias was done in this study only in
three patients. As mentioned before, the validation of non-invasive
continuous BP monitoring system was outside the scope of this
study. In this study, we rather looked for intra-patient linear corre-
lation between non-invasive and invasive BP value changes during
incremental high rates and within a wide range of BP values
(from 41 to 190 mmHg). Indeed, in the clinical practise of interven-
tional electrophysiology, an immediate recognition of sudden
Figure 6 Correlation between beat-to-beat systolic Nexﬁn
blood pressure and invasive blood pressure recorded simul-
taneously in three patients for a wide range of blood pressure
values from 41 to 190 mmHg. Each point is the blood pressure
value of any single beat. The values of each patient are of the
same colour. The blood pressure measurements, baseline and
during ventricular pacing at increasing rates from 100 to
240 bpm, are reported. The black line is the linear regression
line. The less than perfect linear correlation in two patients
may be due to the use of the femoral artery pulse tracing
which is known to provides quite different values and waveforms
from more central vessels.
Non-invasive continuous blood pressure monitoring 1621changes of BP at the onset of tachyarrhythmia is an important
safety parameter which is partially independent of the accuracy
of the absolute BP values and guides the physician’s decision
whether to interrupt the arrhythmia immediately. We found that
Nexﬁn was able to detect immediately sudden changes of BP at
the onset of tachyarrhythmia and that these changes were linearly
correlated with invasive measures, thus providing to be a reliable
method for the safety of the patient and useful for guiding phys-
ician’s decisions.
Conclusions
Continuous non-invasive ﬁnger BP monitoring is feasible and
reliable in the clinical practise of an interventional electrophysi-
ology laboratory without the need of utilization of an intra-arterial
BP line.
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